p16 CDKN2A SNP rs11515 was not associated with head and neck carcinoma
- 189 Downloads
Head and neck squamous cell carcinoma (HNSCC) is considered a serious public health problem in many countries. Recently, genetic variations have been considered as important factors to cancer susceptibility and prognosis. More specifically, genetic polymorphisms have been associated with the development and prognosis of HNSCC. The purpose of the current study was to investigate an association among p16 CDKN2A gene polymorphism at rs11515, age, and HNSCC aggressiveness. PCR–RFLP analysis was used to investigate the p16 CDKN2A gene in 96 patients with HNSCC and in 100 individuals without HNSCC. A case group was categorized by age in younger (<60 years) and older (≥60 years) patients. Differences between the case and control groups were determined using Fisher and chi-squared tests. Time of survival was calculated from the date of diagnosis to the date of last follow-up visit or to the date of death using the Kaplan–Meier estimator and comparing this to the log-rank test. Statistical significance was set at p < 0.05. In the present study, no association was established between HNSCC and rs11515 polymorphism, as indicated in a previous study. We found that HNSCC individuals with large-sized tumors and with metastatic disease presented worse overall survival, consistent with fundamental concepts that establish the effects of tumor size and lymph node metastasis to HNSCC outcomes. This study identified that there is no difference in the distribution of rs11515 between the control and HNSCC groups. In addition, no differences between rs11515 genotypes and clinicopathological parameters were observed.
KeywordsSuppressor gene CDKN2A Polymorphism Cancer Genetic
This study was supported by grants from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Fundação de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). Dr. Guimarães, Dr. Santos, and Dr. de Paula are research fellows of CNPq.
Conflicts of interests
All authors abide by the Association for Medical Ethics’ ethical rules of disclosure.
- 11.Pytynia KB, Grant JR, Etzel CJ, Roberts D, Wei Q, Sturgis EM. Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age. Arch Otolaryngol Head Neck Surg. 2004;130(7):869–73. PubMed PMID: 15262765.CrossRefPubMedGoogle Scholar
- 13.Alves LR, Fraga CA, Oliveira MV, Sousa AA, Jorge AS, Marques-Silva L, et al. High HIF-1alpha expression genotypes increase odds ratio of oral cancer. Head Neck Oncol. 2012;4(5):87. PubMed PMID: 23296286.Google Scholar
- 15.Fraga CA, Sousa AA, Correa GT, Jorge AS, Jesus SF, Jones KM, et al. High hypoxia-inducible factor-1alpha expression genotype associated with Eastern Cooperative Oncology Group performance in head and neck squamous cell carcinoma. Head Neck Oncol. 2012;4(4):77. PubMed PMID: 23250149.Google Scholar
- 16.Correa GT, Bandeira GA, Cavalcanti BG, Santos FB, Neto JF, Guimaraes AL, et al. Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival. Support Care Cancer. 2012. PubMed PMID: 22314971. Epub 2012/02/09. Eng.Google Scholar
- 36.Qiagen (2006) Purification of total DNA from animal tissues. In: DNeasy blood & tissue handbook, Qiagen, ValenciaGoogle Scholar